Cryoanesthesia for Intravitreal Injections

• Status: Completed
• Trial end date: 2018-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The cryoanesthesia (CA) device is designed to provide anesthesia to a focal area on the surface of the eye immediately prior to intraocular injections.

The investigators plan to carry out a pilot study to collect preliminary data on the effectiveness of the cryoanesthesia (CA) device in minimizing the pain caused by intravitreal injections (IVT).

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Michigan
• Treatments: Lidocaine

Criteria

Inclusion Criteria:

• Bilateral macular disease due to either exudative macular degeneration or diabetic retinopathy requiring bilateral intravitreal injections

• Have had at least one prior intravitreal injection

• Able to give informed consent

Exclusion Criteria:

• Unilateral disease

• Unable to provide consent

• Preexisting conjunctival, episcleral or scleral defects or disease